Virtual Reality Headsets for Pain in Sickle Cell Disease Crises
Tests virtual reality headsets alongside usual care in adults with sickle cell disease pain crises.
Key facts
- Who runs it
- University of Maryland, Baltimore
- Where
- Baltimore, United StatesSee the site
- Trial code
- Registry title
- Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Nov 2024
- Expected to end
- 31 Dec 2026
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Virtual Reality Headset and Hand-Held Controllers
- Blindfolding and Noise Cancelling
- Record updated
- 24 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with sickle cell disease who come to the emergency department with acute pain from a vaso-occlusive crisis and are treated with intravenous opioids.
- Age
- Adults over 18 years; people over 89 years old cannot join.
- Sex
- All sexes can join.
- Disease stage
- Sickle cell disease with acute pain thought to be due to a vaso-occlusive crisis; not a complicated crisis.
- Earlier treatment
- Being treated with intravenous opioids for the vaso-occlusive crisis.
Main reasons for not taking part
- Complicated crisis, such as acute chest syndrome, splenic or hepatic sequestration, or pulmonary embolism
- History of seizures or known intolerance to virtual reality
- Vision or hearing problems that prevent using a head-mounted virtual reality device
- Known to be pregnant
- Cannot give informed consent
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Adult (age > 18 years) emergency department patient
- History of sickle cell disease
- Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis
Who cannot take part
- Prior enrollment in this study
- Not being treated with intravenous opioids for the vaso-occlusive crisis
- Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
- Medical history of seizures or known intolerance to virtual reality
- Over the age of 89 years old
- Patients who lack the capacity to provide informed consent
- Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device
- Known to be pregnant
- Incarcerated at the time of evaluation
Where in United States
- University of Maryland Medical SystemsBaltimore, United StatesContact: R. Gentry Wilkerson, MDTaking people
About the trial
What the trial wants to find out
This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.
The 3 groups in the trial
- Active Immersive Virtual RealityTreatment being tested
Patient with sickle cell disease experiencing acute vaso-occlusive crisis randomized to this arm will participate in an active immersive application on the virtual reality headset with hand-held controllers. The active immersive application will allow the user to interact directly with the application and move through the virtual environment .The patient will be able to use the active immersive application on the device for a maximum of two hours.
Treatment: Virtual Reality Headset and Hand-Held Controllers
- Passive Immersive Virtual RealityTreatment being tested
Patient with sickle cell disease experiencing acute vaso-occlusive crisis randomized to this arm will participate in a passive immersive application on the virtual reality headset with hand-held controllers. The passive immersive application will not allow the user to interact directly with the application or move through the virtual environment .The patient will be able to use the passive immersive application on the device for a maximum of two hours.
Treatment: Virtual Reality Headset and Hand-Held Controllers
- Blindfold and Ear PlugsPlacebo, for comparison
Patient with sickle cell disease experiencing acute vaso-occlusive crisis randomized to this arm will wear a blindfold and ear plugs. The patient will be able to remain blindfolded and earplugs for a maximum of two hours.
Treatment: Blindfolding and Noise Cancelling
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Pilot Study to Investigate the Use of Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
- Plain-language title
- Virtual Reality Headsets for Pain in Sickle Cell Disease CrisesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 24 December 2025